New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

FHS
March 13, 2025
10:21 am

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic urothelial cancer.

The value of CNS-specific eCOA provider in clinical trials – Pharmaceutical Technology

CNS assessments should be a consideration for all clinical trials, not just those that are CNS-based. Credit: ESB Professional via Shutterstock. The pharmaceutical industry is

September 4, 2024

Texas A&M researchers win NIH grant to study metabolism in people with Down syndrome

A team of researchers at the Texas A&M University School of Veterinary Medicine & Biomedical Sciences (VMBS) has received a grant from the National Institutes

October 17, 2023

Aetna lawsuit alleges radiology group of fraudulent billing and abuse of federal arbitration

Aetna, the health insurance giant owned by CVS Health, is suing one of the country’s largest networks of radiology practices, alleging a scheme in which

December 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.